The results suggest that these compounds act as uncompetitive inhibitors of AChE, highlighting their potential as promising candidates for the development of therapeutic agents targeting neurodegenerative diseases such as Alzheimer’s, where AChE inhibition is a critical strategy to mitigate disease progression. Here, ACHE is linked to neurodegenerative disease.